Department of Gastroenterology and Hepatology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
Genome Med. 2011 Feb 25;3(2):13. doi: 10.1186/gm227.
Multiple genome-wide association studies (GWASs) and two large scale meta-analyses have been performed for Crohn's disease and have identified 71 susceptibility loci. These findings have contributed greatly to our current understanding of the disease pathogenesis. Yet, these loci only explain approximately 23% of the disease heritability. One of the future challenges in this post-GWAS era is to identify potential sources of the remaining heritability. Such sources may include common variants with limited effect size, rare variants with higher effect sizes, structural variations, or even more complicated mechanisms such as epistatic, gene-environment and epigenetic interactions. Here, we outline potential sources of this hidden heritability, focusing on Crohn's disease and the currently available data. We also discuss future strategies to determine more about the heritability; these strategies include expanding current GWAS, fine-mapping, whole genome sequencing or exome sequencing, and using family-based approaches. Despite the current limitations, such strategies may help to transfer research achievements into clinical practice and guide the improvement of preventive and therapeutic measures.
已经进行了多项全基因组关联研究(GWAS)和两项大型荟萃分析,以研究克罗恩病,并确定了 71 个易感性位点。这些发现极大地促进了我们对疾病发病机制的理解。然而,这些位点仅解释了大约 23%的疾病遗传率。在后 GWAS 时代的未来挑战之一是确定剩余遗传率的潜在来源。这些来源可能包括效应有限的常见变异、效应更高的罕见变异、结构变异,甚至更复杂的机制,如上位性、基因-环境和表观遗传相互作用。在这里,我们概述了这种隐藏遗传率的潜在来源,重点关注克罗恩病和目前可用的数据。我们还讨论了确定更多遗传率的未来策略;这些策略包括扩大当前的 GWAS、精细映射、全基因组测序或外显子组测序,以及使用基于家族的方法。尽管存在当前的限制,但这些策略可能有助于将研究成果转化为临床实践,并指导预防和治疗措施的改进。